STERIS plc (STE) stock
STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 21/303% below fair value
$256.27−0.85 (-0.33%)
Close on Nov 11, 2026Market cap $24.99BP/E 30.4Yield 0.96%
Steris ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Steris's ebitda for the twelve months ending Sep 30, 2026 was $1.66B, up 13.8% year over year. For fiscal 2026 it was $1.59B, up 18.3% from the year before. The highest annual figure on record is $1.59B in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $1.59B | +18.3% |
| FY2025 | Mar 31, 2025 | $1.34B | -4.2% |
| FY2024 | Mar 31, 2024 | $1.40B | +4.3% |
| FY2023 | Mar 31, 2023 | $1.34B | +30.4% |
| FY2022 | Mar 31, 2022 | $1.03B | +34.3% |
| FY2021 | Mar 31, 2021 | $767.61M | +4.5% |
| FY2020 | Mar 31, 2020 | $734.28M | +15.3% |
| FY2019 | Mar 31, 2019 | $636.95M | +10.2% |
| FY2018 | Mar 31, 2018 | $578.22M | +39.5% |
| FY2017 | Mar 31, 2017 | $414.35M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $419.90M | +8.4% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $409.60M | +12.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $440.20M | +30.1% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $395.20M | +6.5% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $387.50M | +15.7% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $365.40M | +22.5% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $338.40M | -4.6% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $371.20M | +1.1% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $335.00M | -2.6% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $298.20M | -11.2% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $354.71M | -60.2% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $367.10M | +11.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $343.81M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $335.69M | +12.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $890.52M | +135.7% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $328.75M | +2.6% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$172.54M | -173.6% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $297.26M | +203.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $377.89M | +85.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $320.54M | +57.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $234.55M | +19.9% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $97.95M | -40.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $203.30M | -2.6% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $203.85M | +6.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $195.68M | +11.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $164.77M | +4.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $208.78M | +9.5% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $191.95M | +26.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $176.37M | +15.5% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $157.19M | +11.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $190.70M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $152.27M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $152.70M | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $141.28M | – |
See a number that looks wrong?